iSonea snags $13.5M; NeuroMetrix rises on FDA clearance;

@FierceMedDev:  ICYM this week's M&A feature - Blockbusters and bloodlettings: A look at 2013's hot start. Special report | Follow @FierceMedDev

 @MarkHFierce: Only a few weeks left to nominate a company for this year's FMD Fierce 15. Submit your nomination | Follow @MarkHFierce

@DamianFierce: Device outfit CVRx has raised $29.6M in a round led by NEA and J&J. Article | Follow @DamianFierce

> Maryland's iSonea raised $13.5 million to market AirSonea, a personal monitoring device that detects airway obstruction in asthma. Release

> NeuroMetrix ($NURO) enjoyed a big bump in its stock price after gaining 510(k) clearance to use its pain-management device during sleep on diabetic patients. Story

> The FDA has assigned its most serious Class I recall label to Verathon's GlideScope Video Laryngoscope, warning that the device's reusable blades can break off and damage patients' airways. More

> California startup SynGen raised $2 million in financing to help advance development of a stem cell harvesting device. Story

> St. Jude Medical's ($STJ) Accent MRI pacemaker, launched recently in Japan, should help the company regain lost market share in the global cardiac rhythm management space, some speculate. Item

> Quest Diagnostics ($DGX) has teamed up with the Centers for Disease Control and Prevention (CDC) to promote hepatitis C screening. News

> Devicemaker Minnetronix has acquired Neurofluidics, a neurocritical care technology specialist. Release

> PathoQuest attracted $5 million in a series B private equity round--money that will help continue development of its diagnostic that relies on next-generation sequencing and cloud-based analysis software. Story (reg. req.)

Biotech News

@FierceBiotech: 2013 Biotech IPOs: The biotech IPO scene turns red hot. Special report | Follow @FierceBiotech

 @JohnCFierce: Deborah Dunsire makes quick leap from Millennium to fast-growing EnVivo. News | Follow @JohnCFierce

@RyanMFierce: Alnylam Pharma spotlights more upbeat human data for gene-silencing drugs. Story | Follow @RyanMFierce

 @EmilyMFierce: Antileukemia compound could also treat common breast cancers. Story | Follow @EmilyMFierce

> Rockwell Medical shares spike on positive PhIII data. Item

> EU, pharma industry pledge $4.4B for R&D projects. Story

> Booming China poised to take a top position in global drug R&D. Article

Pharma News

@FiercePharma: Pharma, FDA still lag in postmarketing safety studies. Getting better, but large % unfinished--or not begun. Yesterday's story | Follow @FiercePharma

 @CarlyHFierce: NICE says 'no' to Celgene's Revlimid. Article | Follow @CarlyHFierce

> New problems for GSK in China as authorities say GSK employees confess to bribery. News

> Vivus hooks up with Menarini to hawk ED pill Spedra in $121M deal. More

Pharma Manufacturing News

 @EricPFierce: BioPlan says China, India losing luster for outsourced biopharmaceutical manufacturing. More | Follow @EricPFierce

> Wockhardt faces 2nd import alert. Report

> Sanofi's ImmuCyst available in next year, Alliance Pharma says. More

> Pfizer to invest $130M in 2 plants in Ireland. News

> Contract manufacturer Piramal also into development, cellphones. Story

Vaccines News

> Manufacturers prepare for resurgence of H7N9. News

> Robot eases kids' vaccination distress in study. More

> Novartis inks typhoid vax licensing deal with Biological E. Story

> U.K. mumps outbreak linked to waning MMR protection. Report

Suggested Articles

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.